Meg C 2 500mg/500mg Injection
Marketer
Ridhima Biocare
Salt Composition
Imipenem (500mg) + Cilastatin (500mg)
Overview Meg C 2 500mg/500mg Injection
Combiflox 500mg/500mg Injection, a dual-antibiotic formulation, combats severe bacterial infections. Administered only by a healthcare provider, it targets infectious microorganisms to prevent infection spread. Complete the prescribed dosage, even with symptom improvement; missed doses should be avoided. Common reactions include nausea, vomiting, diarrhea, and skin rashes. Injection site soreness, redness, and swelling may occur but typically subside. Worsening side effects necessitate immediate medical attention. Seek immediate help for allergic reactions (rash, itch, swelling, breathing difficulty). Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol should be avoided due to potential increased drowsiness. While typically non-impairing, driving should be avoided if drowsiness or dizziness occurs.
Primary Ingredients of Meg C 2 500mg/500mg Injection
There is no text provided to rewrite.
Uses of Meg C 2 500mg/500mg Injection
Life-threatening bacterial infections
Major Benefits of Meg C 2 500mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Meg C 2 500mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
How to use Meg C 2 500mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Meg C 2 500mg/500mg Injection works:
Meg C 2 500mg/500mg Injection unites imipenem, a bacterial growth inhibitor, with cilastatin, a dehydropeptidase I inhibitor. Imipenem's antibiotic action disrupts bacterial cell wall synthesis, crucial for bacterial viability. Cilastatin safeguards imipenem from premature degradation by dehydropeptidase I, prolonging its therapeutic effect within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Meg C 2 500mg/500mg Injection lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
The use of Meg C 2 500mg/500mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Administration of Meg C 2 500mg/500mg Injection during lactation is likely safe. Available human data indicate minimal infant risk associated with the medication.
DrivingUNSAFE
Administration of Meg C 2 500mg/500mg Injection can induce adverse reactions potentially impairing driving capabilities. Certain reported side effects, including hallucinations (visual, auditory, or sensory), may compromise safe driving for some individuals.
KidneyCAUTION
Patients with kidney impairment should use Meg C 2 500mg/500mg Injection cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Meg C 2 500mg/500mg Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Meg C 2 500mg/500mg Injection :
Should you forget a scheduled dose of Meg C 2 500mg/500mg Injection, seek medical advice.
Facts to Know About Meg C 2 500mg/500mg Injection
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently